Check-Cap(CHEK) - 2022 Q3 - Quarterly Report

Exhibit 99.1 Check-Cap Reports Third Quarter 2022 Financial Results and Provides a Corporate Update ISFIYA, Israel, November 30, 2022 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer (CRC), today announced financial results and provided a corporate update for th ...